感谢您的关注和对公司相关分红工作的建议。公司相关信息以在指定媒体《证券时报》《证券日报》及 巨潮资讯网发布的信息为准，请您甄别并注意投资风险。本次定增工作旨在为公司发展提供资金支持， 发行价格符合相关规则。公司将多措并举加快公司发展以增强投资者信心。查看更多董秘问答>> 投资者提问： 免责声明：本信息由新浪财经从公开信息中摘录，不构成任何投资建议；新浪财经不保证数据的准确 性，内容仅供参考。 贵公司2016-2017"皮草生意坏账"事件，公司被ST，该事件公司治理存在重大缺陷引发的资金挪用，透 支公司多年经营利润，更早期间贵公司还存在财务造假，目前贵公司搞了个低价定增而不是溢价也严重 影响市场信心，贵公司如何重新提振资本信心？有什么实际举措？比如送股分红等方式提高投资者回报 还可以减少现金分红 董秘回答(国投丰乐SZ000713)： ...

Core Viewpoint - The capital operations of Beilu Pharmaceutical, involving significant shareholder sell-offs and a planned private placement, raise questions about the underlying logic and potential market implications [1][2][3] Group 1: Shareholder Actions - Major shareholders, including Chongqing Three Gorges Paint Co., Ltd., have been actively reducing their stakes, with plans to sell up to 9.7 million shares, representing 1.98% of total shares [1] - From March 25 to June 19, 2025, Chongqing Three Gorges Paint reduced its holdings by 2.9988 million shares, decreasing its ownership from 8.23% to 7.59%, resulting in approximately 22 million yuan in cash [1] - The actual controller, Wang Daixue, also sold 7.3783 million shares in July 2025 for nearly 60 million yuan, following a previous sale of 9.7893 million shares in 2023 for over 66 million yuan [2] Group 2: Private Placement Details - Beilu Pharmaceutical announced plans to raise up to 300 million yuan through a simplified procedure for a private placement, aimed at funding the construction of a pharmaceutical production workshop and upgrading raw material production lines [1] - The pricing for the private placement has not been finalized but will be set at no less than 80% of the average price over the 20 trading days prior to the issuance date, raising concerns about potential arbitrage opportunities if the placement price is lower than the recent sell-off prices [2] - Historical context shows that in 2015, Beilu's private placement price was 12.9 yuan per share, while the market price remained above 15 yuan, leading to significant unrealized gains for participating shareholders [2]

Core Viewpoint - The convertible bond conversion process of Yong'an Hang is nearing completion after a lengthy four-year struggle, with the unconverted bond ratio dropping to 13.61% as of August 4, 2023, following a series of announcements regarding the bond's delisting and conversion timeline [1][6]. Group 1: Convertible Bond Details - Yong'an Hang announced that its "Yong'an Convertible Bond" will be delisted from the Shanghai Stock Exchange on August 12, 2025, with the last conversion date set for August 11, 2025, and a conversion price of 14.22 yuan per share [2]. - The bond was initially issued on December 23, 2020, with a total scale of 886.48 million yuan and a six-year term, entering the conversion period on May 31, 2021, with an initial conversion price of 20.34 yuan per share [2][3]. - The bond's unconverted ratio was as high as 82.8% due to the company's long-term low stock price, which reached a historical low of 7.13 yuan in February 2024 [3][6]. Group 2: Company Financials and Challenges - Yong'an Hang has faced continuous losses for three consecutive years, with an expected net loss of 62 million to 80 million yuan for the first half of 2025, primarily due to insufficient growth in its public bicycle project and delayed payments from government clients [8][10]. - The company has announced a significant delay in its core fundraising project, extending the timeline for the "Smart System Design and Deployment Project" from November 2022 to December 2027, citing macroeconomic impacts and operational challenges [10][11]. - Yong'an Hang's recent fundraising efforts include an 840 million yuan private placement at a price of 11.70 yuan per share, which is approximately 54% of the current market price, raising questions about the necessity of this financing given the company's current cash position and previous fundraising performance [10][11].

Core Viewpoint - The article discusses the recent changes in the management and ownership of Guangyun Da, highlighting the company's financial struggles and the implications of its capital operations, including high-premium acquisitions and low-priced private placements [1][6][7]. Company Overview - Guangyun Da (300227.SZ) is the first listed company in China's laser application industry, focusing on products and services in electronic and aerospace manufacturing, including 3D printing and precision laser drilling [3]. - The company has experienced a continuous decline in performance since 2020, with a projected loss of 48 million in net profit for 2024 [4][5]. Financial Performance - The company's net profit has shown a significant downward trend, with a 352% year-on-year decline in the first quarter of 2025 [5][10]. - From 2019 to 2024, the company's net profit decreased from 72.1 million to -27.4 million, indicating a severe financial downturn [10]. Ownership Change - In September 2024, the original controlling shareholders transferred 5.2% of their shares to Junfei Investment for 230 million, representing a 62.5% premium over the previous day's closing price [11][14]. - Following the ownership change, the new management team, led by Zeng Sanlin and Cheng Fei, lacks experience in the laser industry, raising concerns about their ability to navigate the company's challenges [21][24]. Capital Operations - The company is planning to acquire Yilian Unlimited for up to 650 million, despite its own financial difficulties, which raises questions about the rationale behind such a high-value acquisition [36][71]. - Yilian Unlimited's previous IPO attempt failed, and the acquisition is seen as a way for Guangyun Da to quickly gain market presence in the network communication equipment sector [40][64]. Market Position and Risks - Yilian Unlimited has shown significant revenue growth, but its market share remains low at 2%, and it heavily relies on a few major clients, which poses risks [52][57]. - The article suggests that Guangyun Da's strategy appears to prioritize capital expansion over strengthening its core business, which could lead to increased financial strain and operational challenges [70][71].